With Cincinnati Reds left-hander Andrew Abbott taking the mound against the hosting Colorado Rockies on Monday night, second baseman Ryan McMahon will get the day off for Colorado. It's just the second time all season that McMahon won't be in the starting lineup for the Rockies. The 29-year-old left-handed hitter is slashing a solid .284/.371/.470 with an .841 OPS, 10 home runs, 34 RBI and 29 runs scored in 215 at-bats and 58 games so far in 2024. He's actually been better against southpaws, going 23-for-68 (.338) with four of his 10 home runs against them. McMahon could use a breather, though, as he's hitting just .191 (8-for-42) with three homers and nine RBI in the last two weeks. Alan Trejo is starting at the keystone and hitting ninth for the Rockies on Monday against Abbott. Trejo has only four hits in 37 at-bats this year and should be avoided for DFS play.

Houston Astros starting pitcher Jose Urquidy (forearm), who was recently pulled from his minor-league rehab start, will soon visit with Dr. Keith Meister in Dallas and could be headed for the second Tommy John surgery of his career, according to sources. Urquidy is having a second opinion on his injured right forearm after already consulting with a specialist after he was pulled from his rehab assignment with Triple-A Sugar Land late last month. The 29-year-old veteran was shut down in mid-March in spring training with a right-forearm strain and has yet to pitch at all in 2024 for Houston. Urquidy also missed a big chunk of time in 2023 and could be on his way to missing the entire 2024 campaign. The upside was very limited to begin with for Urquidy, and now it looks like he may not be back until around midseason in 2025.

Baltimore Orioles left-hander John Means (elbow) underwent the second Tommy John surgery of his career on Monday, and his second such operation in two years. The recovery timeline is 12 to 18 months, meaning that Means will miss the rest of this season and at least half of 2025. The 31-year-old southpaw is set to be a free agent after the 2024 campaign, so it's a really bad time for him to have another elbow reconstruction. His first Tommy John surgery came in April of 2022. Given the lengthy rehab he has in front of him, Means is likely to remain on the free-agent market for a while before interested teams take a chance on him for 2025 and beyond. Means was a first-time All-Star back in 2019, but the elbow injuries continue to mount and he's made just 10 starts for Baltimore since the start of the 2022 season.

San Diego Padres infielder Tucupita Marcano is facing a potential lifetime ban from the game for betting on baseball, according to sources. Major League Baseball continues to investigate Marcano, but they could hand down their penalty against him soon. Along with facing a potential lifetime ban, the 24-year-old has been on the injured list all year as he recovers from a torn ACL he suffered last year while playing for the Pittsburgh Pirates. The Venezuelan infielder made his major-league debut in 2021 with the Padres and has appeared in the majors each of the last two years as well, batting just .217/.269/.320 with five home runs, 34 RBI, seven stolen bases and 41 runs scored in 149 games as a depth piece for the Padres and Pirates.

Philadelphia Phillies left-hander Ranger Suarez (hand) is doing better and will play catch on Tuesday before throwing a bullpen session on Wednesday. If he comes out of his bullpen on Wednesday no worse for wear, he'll be in play for the London series this weekend against the division-rival New York Mets. The 28-year-old southpaw only went two innings in his last start on Saturday against the St. Louis Cardinals and had to leave early after taking a line-drive comebacker off his left hand. The good news is that X-rays came back negative, so Suarez may not have to miss a start at all. With extra off days coming up, the Phillies could elect to play it safe and push Suarez back. Even though he'll be more of a risk in his next start coming off the injury, Suarez has been one of the best pitchers in the league in 2024. We're not going to recommend sitting a pitcher that's been as good as he has.